[Retracted] KIF20A Predicts Poor Survival of Patients and Promotes Colorectal Cancer Tumor Progression through the JAK/STAT3 Signaling Pathway

Table 2

Oncomine analysis of KIF20A expression in colorectal cancer (total 9 colorectal cancer cohorts).

Cohort no.	Cohort	Sample ()	-test	Fold change	value
1	Hong colorectal [23]	Colorectal carcinoma (70) vs. normal (12)	10.005	2.891
2	Skrzypczak colorectal 2 [24]	Colon carcinoma (5) vs. normal (10)	9.362	5.046
		Colon adenoma (5) vs. normal (10)	7.856	4.145
		Colon carcinoma epithelia (5) vs. normal (10)	5.083	2.268
		Colon adenoma epithelia (5) vs. normal (10)	3.671	1.828	0.002
3	Ki colon [25]	Colon adenocarcinoma (50) vs. normal (28)	2.233	1.177	0.014
4	Skrzypczak colorectal [24]	Colorectal carcinoma (36) vs. normal (24)	5.842	2.198
		Colorectal adenocarcinoma (45) vs. normal (24)	5.596	2.058
5	Graudens colon [26]	Colorectal carcinoma (18) vs. normal (12)	3.397	1.308	0.001
6	Sabates-Bellver colon [27]	Rectal adenoma (7) vs. normal (32)	7.728	3.537
		Colon adenoma (25) vs. normal (32)	11.436	3.033
7	Kaiser colon [28]	Rectal mucinous adenocarcinoma (4) vs. normal (5)	2.892	1.588	0.014
		Cecum adenocarcinoma (17) vs. normal (5)	4.901	2.127	0.002
		Rectosigmoid adenocarcinoma (10) vs. normal (5)	2.989	1.727	0.007
		Colon adenocarcinoma (41) vs. normal (5)	4.544	1.976	0.003
		Colon mucinous adenocarcinoma (13) vs. normal (5)	3.27	1.893	0.004
		Rectal adenocarcinoma (8) vs. normal (5)	1.685	1.458	0.06
8	TCGA colorectal	Cecum adenocarcinoma (22) vs. normal (22)	8.124	2.891
		Colon mucinous adenocarcinoma (22) vs. normal (22)	8.048	2.77
		Rectosigmoid adenocarcinoma (3) vs. normal (22)	2.789	1.767	0.031
		Colon adenocarcinoma (101) vs. normal (22)	8.765	2.678
		Rectal adenocarcinoma (60) vs. normal (22)	8.145	2.563
		Rectal mucinous adenocarcinoma (6) vs. normal (22)	6.021	3.112
9	Gaspar colon [29]	Colorectal adenoma epithelia (56) vs. normal (22)	2.908	1.213	0.003